Issued Patents All Time
Showing 1–25 of 47 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12247020 | Bipyrazole derivatives as JAK inhibitors | Yun-Long Li, Jincong Zhuo, Song Mei, Ganfeng Cao, Yongchun Pan +2 more | 2025-03-11 |
| 12084449 | Imidazotriazines and imidazopyrimidines as kinase inhibitors | Jincong Zhuo, Meizhong Xu, Chunhong He, Colin Zhang, David M. Burns +3 more | 2024-09-10 |
| 11981671 | Bicyclic pyrazolyl amines as CDK2 inhibitors | Joshua Hummel, Jingwei Li, Liangxing Wu | 2024-05-14 |
| 11976073 | Bicyclic amines as CDK2 inhibitors | Joshua Hummel, David M. Burns, Xiaozhao Wang | 2024-05-07 |
| 11905275 | Bipyrazole derivatives as JAK inhibitors | Yun-Long Li, Jincong Zhuo, Song Mei, Ganfeng Cao, Yongchun Pan +2 more | 2024-02-20 |
| 11851426 | Bicyclic amines as CDK2 inhibitors | Yingda Ye, Zhenwu Li, Sarah Winterton, Liangxing Wu, Wenqing Yao | 2023-12-26 |
| 11673894 | Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors | Xiaozhao Wang, Pei Gan, Taisheng Huang, Chao Qi, Liangxing Wu +5 more | 2023-06-13 |
| 11673883 | Heterocyclic compounds as immunomodulators | Liang Lu, Liangxing Wu, Wenqing Yao | 2023-06-13 |
| 11667635 | Bicyclic heterocycles as FGFR4 inhibitors | Liang Lu, Liangxing Wu, Wenqing Yao | 2023-06-06 |
| 11591318 | Bipyrazole derivatives as JAK inhibitors | Yun-Long Li, Jincong Zhuo, Song Mei, Ganfeng Cao, Yongchun Pan +2 more | 2023-02-28 |
| 11472791 | Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors | Joshua Hummel, Jingwei Li, Zhenwu Li, Liangxing Wu, Kaijiong Xiao +8 more | 2022-10-18 |
| 11339149 | Heterocyclic compounds as immunomodulators | Liangxing Wu, Jingwei Li, Wenqing Yao, Chao Qi, Fenglei Zhang | 2022-05-24 |
| 11261191 | Imidazotriaines and imidazopyrimidines as kinase inhibitors | Jincong Zhuo, Meizhong Xu, Chunhong He, Colin Zhang, David M. Burns +3 more | 2022-03-01 |
| 11014923 | Bicyclic heterocycles as FGFR4 inhibitors | Liang Lu, Liangxing Wu, Wenqing Yao | 2021-05-25 |
| 11001571 | Bipyrazole derivatives as JAK inhibitors | Yun-Long Li, Jincong Zhuo, Song Mei, Ganfeng Cao, Yongchun Pan +2 more | 2021-05-11 |
| 10947230 | Bicyclic heterocycles as FGFR inhibitors | Yaping Sun, Wenqing Yao, Liangxing Wu, Meizhong Xu, Fenglei Zhang | 2021-03-16 |
| 10851105 | Bicyclic heterocycles as FGFR4 inhibitors | Liangxing Wu, Liang Lu, Bo Shen, Wenqing Yao | 2020-12-01 |
| 10806785 | Immunomodulator compounds and methods of use | Liang Lu, Wenyu Zhu, Kaijiong Xiao | 2020-10-20 |
| 10800768 | Heterocyclic compounds as immunomodulators | Liangxing Wu, Jingwei Li, Wenqing Yao, Chao Qi, Fenglei Zhang | 2020-10-13 |
| 10738052 | Imidazotriaines and imidazopyrimidines as kinase inhibitors | Jincong Zhuo, Meizhong Xu, Chunhong He, Colin Zhang, David M. Burns +3 more | 2020-08-11 |
| 10738048 | Bicyclic heterocycles as FGFR4 inhibitors | Liang Lu, Liangxing Wu, Wenqing Yao | 2020-08-11 |
| 10513493 | Cyclopropylamines as LSD1 inhibitors | Liangxing Wu, Chunhong He, Bo Shen, Wenqing Yao | 2019-12-24 |
| 10435392 | Bipyrazole derivatives as JAK inhibitors | Yun-Long Li, Jincong Zhuo, Song Mei | 2019-10-08 |
| 10214528 | Bicyclic heterocycles as FGFR4 inhibitors | Liang Lu, Liangxing Wu, Wenqing Yao | 2019-02-26 |
| 9957229 | Amido compounds and their use as pharmaceuticals | Wenqing Yao, Jincong Zhuo, Meizhong Xu, Colin Zhang, Brian W. Metcalf +1 more | 2018-05-01 |